Here are the key details to know:
1. Through completion of the merger, Envision is a wholly-owned subsidiary of KKR.
2. Envision stockholders will receive $46 per share as a result of the merger.
3. The $9.9 billion acquisition was announced in June.
4. Following the acquisition, Envision (AmSurg) will have about 300 ASCs in its porfolio.
More articles on transactions and valuation:
KKR will have about 300 ASCs in its portfolio after Envision acquisition
Surgery Partners renews M&A push with plans to raise $115M — 7 insights
3 experts share their thoughts on surgery center M&A
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.